Is staphylococcal screening and suppression an effective interventional strategy for reduction of surgical site infection?

Surgical Infections

Volumn 17, Issue 2, 2016, Pages 158-166

  Edmiston, Charles E ^a   Ledeboer, Nathan A ^a   Buchan, Blake W ^a   Spencer, Maureen ^b   Seabrook, Gary R ^a   Leaper, David ^b,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Infection Prevention Consultants   (United States)

^c UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CEFOXITIN; CHLORHEXIDINE GLUCONATE; CHROMOGENIC SUBSTRATE; DOXYCYCLINE; METICILLIN; OXACILLIN; PLACEBO; PSEUDOMONIC ACID; RIFAMPICIN; ANTIINFECTIVE AGENT;

AGGLUTINATION TEST; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL DECOLONIZATION; BACTERIUM CULTURE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; CULTURE MEDIUM; DIAGNOSTIC ACCURACY; DISK DIFFUSION; ELECTIVE SURGERY; EVIDENCE BASED PRACTICE; GOLD STANDARD; HEALTH CARE COST; HOSPITAL READMISSION; HUMAN; INAPPROPRIATE PRESCRIBING; INFECTION RISK; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LABORATORY TEST; LIMIT OF DETECTION; MEDIASTINITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NOSE SMEAR; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION SYSTEM; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SCREENING; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL BACTEREMIA; SURGICAL INFECTION; SURGICAL PATIENT; TURNAROUND TIME; ULTRAVIOLET RADIATION; HETEROZYGOTE; MASS SCREENING; PREVENTION AND CONTROL; PROCEDURES; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; UTILIZATION;

ANTI-BACTERIAL AGENTS; CARRIER STATE; HUMANS; MASS SCREENING; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

EID: 84962549354     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2015.257     Document Type: Review

References (75)

1. Gould I. Costs of hospital-Acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. Int J Antimicrob Agents 2006; 28: 379-384
2. Leaper DJ, van Goor H, Reilly J, et al. Surgical site infection-A European perspective of incidence and economic burden. Int Wound J 2004; 1: 247-273
3. Health Protection Agency. 5th report of the mandatory surveillance of surgical site infection in orthopedic surgery April 2004-March 2009. London: Health Protection Agency; December 2011, www.hpa.org.uk
4. Leaper D, Tanner J, Kiernan M. Surveillance of surgical site infection: More accurate definitions and intensive recording needed. J Hosp Infect 2013; 83: 83-86
5. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guidelines for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24: 362-386
6. Weber SG, Huang SS, Oriola S, et al. Legislative mandates for use of active surveillance cultures to screen for methicillinresistant Staphylococcus aureus and vancomycin-resistant enterococci: A position statement from the joint SHEA and APIC taskforce. Infect Control Hosp Epidemiol 2007; 28: 249-260
7. Peterson A, Marquez P, Terashita D, et al. Hospital methicillin-resistant Staphylococcus aureus active surveillance practices in Los Angeles County: Implications of legislation-based infection control 2008.AmJ Infect Control 2010; 38: 653-656
8. Longmire W, Altemeier WA, Blades B, et al. Postoperative wound infections: The influence of ultraviolet irradiation on the operating room and various other factors. Ann Surg 1964; 160: 1-92
9. Wertheim WFL, Melles C, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5: 751-762
10. Nouwen JL, Fierren MW, Snijders S, et al. A persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int 2005; 67: 1084-1092
11. Nouwen JL, Ott A, Kluytmans-Vandenbergh MF, et al. Predicting the Staphylococcus aureus nasal carrier state: Derivation and validation of a culture rule. Clin Infect Dis 2004; 39: 806-811
12. Hu I, Umeda A, Kondo S, et al. Typing of Staphylococcus aureus colonizing human s nasal carriers by pulse-field gel electrophoresis. J Med Microbiol 1995; 42: 127-132
13. Nouwen JL, Boelens H, van Belkum A, et al. Human factors in Staphylococcus aureus nasal carriage. Infect Immun 2004; 72: 6685-6688
14. Parnaby RM, O Dwyer G, Monsey HA, et al. Carriage of Staphylococcus aureus in the elderly. J Hosp Infect 1996; 33: 201-206
15. Lipsky RM, Percoraro RE, Chen MS, et al. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 1987; 10: 483-486
16. Kirmani N, Tuazon CU, Murray HW, et al. Staphylococcus aureus carriage rate of patients receiving long-Term dialysis. Arch Intern Med 1978; 138: 1657-1659
17. Luzar MA, Coles GA, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patents on continuous ambulatory peritoneal dialysis. N Eng J Med 1990; 322: 505-509
18. Chang FY, Singh N, Gayowski T, et al. Staphylococcus aureus nasal colonization and association with infection in liver transplant recipient. Transplantation 1998; 65: 1169-1172
19. Nguyen MH, Kauffman CA, Goodman RP, et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 1999; 130: 221-225
20. Steele RW. Recurrent staphylococcal infection in families. Arch Dermatol 1980; 116: 189-190
21. Herwaldt IA, Cullen JJ, French P, et al. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 2004; 481-484
22. White A, Smith J. Nasal reservoir as the source of extra nasal staphylococci. Antimicrob Agents Chemother 1963; 161: 679-683
23. Henderson RJ, Williams RE. Nasal disinfection in prevention of postoperative staphylococcal infection in wounds. Br Med J 1961; 5248: 330-333
24. Perl TM, Cullen JJ, Wenzel RP, et al. Mupirocin and the risk of Staphylococcus aureus Study Team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infection. N Eng J Med 2010; 362: 9-17
25. Kalmerijer MD, van Nieuwland-Bollen E, Bogaers-Hoffman D, et al. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000; 21: 319-323
26. Kluytmans JA, Mouton JW, Ijzerman EP, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infection after cardiac surgery. J Infect Dis 1995; 171: 216-219
27. Fry DE, Barie PD. The changing face of Staphylococcus aureus: Acontinuing surgical challenge. Surg Infect 2011; 12: 191-203
28. Jarvis WR, Jarvis JA, Chinn RY. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United State healthcare facilities, 2010. Am J Infect Control 2012; 40: 194-200
29. Jarvis WR, Schlosser J, Chinn RY, et al. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US healthcare facilities, 2006. Am J Infect Control 2007; 35: 631-637
30. Cunningham R, Jenks SP, Northwood J, et al. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect 2007; 65: 24-28
31. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; 21st informational supplement. M100-S21, 2011
32. Mohanasoundaram KM, Lalitha MK. Comparison of phenotypic versus genotypic methods in the detection of methicillin resistance in Staphylococcus aureus. Indian J Med Res 2008; 127: 78-84
33. Cavassini M, Wenger A, Jaton K, et al. Evaluation of MRSA-Screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol 1999; 37: 1591-1594
34. Chediac-Tannoury R, Araj GF. Rapid MRSA detection by a latex kit. Clin Lab Sci 2003; 16: 198-202
35. CLSI Performance standards for antimicrobial susceptibility testing. CLSI approved standard M100-S17, 2007
36. Buchan BW, Ledeboer NA. Identification of two borderline oxacillin-resistant strains of Staphylococcus aureus from routine nares swab specimens by one of three chromogenic agars evaluated for the detection of MRSA. Am J Clin Pathol 2010; 134: 921-927
37. Peterson JF, Riebe KM, Hall GS, et al. Spectra MRSA, a new chromogenic agar medium to screen for methicillinresistant Staphylococcus aureus. J Clin Microbiol 2010; 48: 215-219
38. Carson J, Lui B, Rosmus L, et al. Interpretation of MRSA Select screening agar at 24 hours of incubation. J Clin Microbiol 2009; 47: 566-568
39. Peterson LR, Liesenfeld O, Woods CW, et al. Multicenter evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test as a rapid method for detection of MRSA in nasal surveillance swabs. J Clin Microbiol 2010; 48: 1661-1666
40. Bartels MD, Boye K, Rohde SM, et al. A common variant of staphylococcal cassette chromosome mec type IVa in isolates from Copenhagen, Denmark, is not detected by the BD GeneOhm methicillin-resistant Staphylococcus aureus assay. J Clin Microbiol 2009; 47: 1524-1527
41. Snyder JW, Munier GK, Heckman SA, et al. Failure of the BD GeneOhm StaphSR assay for direct detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates in positive blood cultures collected in the United States. J Clin Microbiol 2009; 47: 3747-3748
42. Balslev U, Bremmelgaard A, Svejgaard E, et al. An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit. Microb Drug Resist 2005; 11: 78-81
43. Cuny C, Pasemann B, Witte W. Detection of oxacillin resistance in Staphylococcus aureus by screening tests. Eur J Clin Microbiol Infect Dis 1999; 18: 834-836
44. McDougal LK, Thornsberry C. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Microbiol 1985; 23: 832-839
45. Wolk DM, Picton E, Johnson D, Davis T, Pancholi P, et al. Multicenter evaluation of the Cepheid Xpert methicillinresistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol 2009; 47: 758-764
46. Wassenberg M, Kluytmans J, Erdkamp S, et al. Costs and benefits of rapid screening of methicillin-resistant Staphylococcus aureus carriage in intensive care units: A prospective multicenter study. Crit Care 2012; 16: R22
47. Patel PA, Ledeboer NA, Ginocchio CC, et al. Performance of the BD GeneOhm MRSA achromopeptidase assay for real-Time PCR detection of methicillin-resistant Staphylococcus aureus in nasal specimens. J Clin Microbiol 2011; 49: 2266-2268
48. Malhotra-Kumar S, Van Heirstraeten L, Lee A, et al. Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2010; 48: 4598-4601
49. Wendt C, Havill NL, Chapin KC, et al. Evaluation of a new selective medium, BD BBL CHROMagar MRSA II, for detection of methicillin-resistant Staphylococcus aureus in different specimens. J Clin Microbiol 2010; 48: 2223-2227
50. Pofahl WE, Goettler CE, Ramsey KM, et al. Active surveillance screening of MRSA and eradication of carrier state decreases surgical-site infections caused by MRSA. J Am Coll Surg 2009; 208: 981-988
51. San Juan R, Chaves F, Gude MJL, et al. Staphylococcus aureus poststernotomy mediastinitis: Description of two distinct acquisition pathways with different potential preventative approaches. J Thorac Cardiovasc Surg 2007; 134: 670-676
52. Van Rijen MML, Bode LG, Baak DA, et al. Reduced costs for Staphylococcus aureus carriers treated prophylactically with mupirocin and chlorhexidine in cardiothoracic and orthopediac surgery. PLOS one 2013; 7: e43065
53. Kim DH, Spencer M, Davidson SM, et al. Institutional prescreening for detection and eradication of methicillin in patients undergoing elective orthopedic surgery. J Bone Joint Surg 2010; 92: 1820-1826
54. Edmiston CE, Seabrook GR, Cambria RA, et al. Molecular epidemiology of microbial contamination in the operating room environment: Is there a risk for infections? Surgery 138: 572-588
55. Harbarth S, Frankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008; 299: 1149-1157
56. Kavanagh K, Abusalem S, Saman DM. A perspective on the evidence regarding methicillin-resistant Staphylococcus aureus surveillance. J Patient Saf 2012; 8: 140-143
57. Henteleff HJ, Barie PS, Hamilton SM. Members of the Evidence-Based Reviews in Surgery Group. Universal screening for methicillin-resistant Staphylococcus aureus in surgical patients. J Am Coll Surg 2010; 212: 833-835
58. Huskins WC, Huckabee CM, O Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Eng J Med 2011; 364: 1407-1418
59. Jain R, Kralovic SM, Evans ME, et al. Veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Eng J Med 2011; 364: 1419-1430
60. Tacconelli E, Carmeli Y, Aizer A, et al. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: A meta analysis. Clin Infect Dis 2003; 37: 1629-1638
61. Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infection: Systematic review of the literature and meta-Analysis. Infect Control Hosp Epidemiol 2005; 26: 916-922
62. Cimochowski CE, Harostock MD, Brown R, et al. Intranasal mupriocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 2011; 71: 1572-1579
63. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al. Surgical site infections in orthopedic surgery: The effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2001; 35; 353-358
64. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Eng J Med 2002; 346: 1871-1877
65. Keshtgar MR, Khalili A, Coen PG, et al. Impact of rapid molecular screening for methicillin-resistant Staphylococcus aureus in surgical wards. British J Surg 2008; 95: 381-386
66. Bode LGM, Kluytmans AJW, Wertheim HFL, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. New Eng J Med 2010; 362: 9-17
67. Simor AE, Phillips E, McGeez A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007; 44: 178-185
68. Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin resistance. Clin Infect Dis 2009; 49: 935-941
69. Deeny SR, Worby CJ, Auguet AT, et al. Impact of mupirocin resistance on the transmission and control of healthcareassociated MRSA. J Antimicrob Chemother 2015; 70: 3366-3378
70. McGinigle KL, Gourlay ML, Buchanan IB. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: A systematic review. Clin Infect Disease 2008; 46: 1717-1725
71. Kang J, Mandsager P, Bidle AK, et al. Cost-effectiveness analysis of active surveillance screening for methicillinresistant Staphylococcus aureus in an academic hospital setting. Infect Control Hosp Epidemiol 2012; 33: 477-486
72. Hubben G, Bootsma M, Luteijn M, et al. Modelling the cost and effect of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureus. Plos One 2011; 6: e14783
73. Peterson LR, Hacek DM, Robicsek A. 5 million lives campaign. Case study: An MRSA intervention at Evanston Northwestern Healthcare. Jt Comm J Qual Patient Safety 2007; 33: 732-738
74. Peterson LR, Diekema DJ. Point-counterpoint: To screen or not to screen for methicillin-resistant Staphylococcus aureus. J Clin Microbiology 2010; 48: 683-689
75. Edmiston CE, Lee CJ, Krepel CJ, et al. Evidence for a standardized preadmission showering regimen to achieve maximal antiseptic skin surface concentrations of chlorhexidine gluconate, 4%, in surgical patients. JAMA Surg 2015; 150: 1027-1033